loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2015_251___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Signa S.A. de C.V.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SIGNA S.A. DE C.V. Toluca MX (1)

    filter

    01 Imatinib mesilate (1)

    filter

    01 Mexico (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    SIGNA S.A. DE C.V. Toluca MX

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Mexico
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Imatinib mesilate

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2015-251 - Rev 03
    Expired
    Chemical
    2019-02-14
    2021-11-25
    2736
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2015-251 - Rev 03 of Signa S.a. De C.v. Toluca Mx

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2015-251 - Rev 03 of Signa S.a. De C.v. Toluca Mx 1

    20

    Signa S.a. De C.v. Toluca Mx, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Imatinib mesilate, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2015-251 - Rev 03

    This Chemical Type CEP, issued on February 14, 2019, remains in force until November 25, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2736 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY